140 related articles for article (PubMed ID: 9291187)
1. N-glycosylation is not essential for enzyme activity of 11beta-hydroxysteroid dehydrogenase type 2.
Kyossev ZN; Reeves WB
Kidney Int; 1997 Sep; 52(3):682-6. PubMed ID: 9291187
[TBL] [Abstract][Full Text] [Related]
2. Mutations in putative glycosylation sites of rat 11 beta-hydroxysteroid dehydrogenase affect enzymatic activity.
Agarwal AK; Mune T; Monder C; White PC
Biochim Biophys Acta; 1995 Apr; 1248(1):70-4. PubMed ID: 7711058
[TBL] [Abstract][Full Text] [Related]
3. Ontogeny and sexual dimorphic expression of mouse type 2 11beta-hydroxysteroid dehydrogenase.
Condon J; Ricketts ML; Whorwood CB; Stewart PM
Mol Cell Endocrinol; 1997 Mar; 127(2):121-8. PubMed ID: 9099907
[TBL] [Abstract][Full Text] [Related]
4. Subcellular localization of the type 2 11beta-hydroxysteroid dehydrogenase. A green fluorescent protein study.
Náray-Fejes-Tóth A; Fejes-Tóth G
J Biol Chem; 1996 Jun; 271(26):15436-42. PubMed ID: 8663122
[TBL] [Abstract][Full Text] [Related]
5. 11beta-hydroxysteroid dehydrogenase type 2 is the predominant isozyme in the guinea pig placenta: decreases in messenger ribonucleic acid and activity at term.
Sampath-Kumar R; Matthews SG; Yang K
Biol Reprod; 1998 Dec; 59(6):1378-84. PubMed ID: 9828181
[TBL] [Abstract][Full Text] [Related]
6. The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes.
Krozowski Z; Li KX; Koyama K; Smith RE; Obeyesekere VR; Stein-Oakley A; Sasano H; Coulter C; Cole T; Sheppard KE
J Steroid Biochem Mol Biol; 1999; 69(1-6):391-401. PubMed ID: 10419017
[TBL] [Abstract][Full Text] [Related]
7. The role of 11beta-hydroxysteroid dehydrogenase in steroid hormone specificity.
Náray-Fejes-Tóth A; Colombowala IK; Fejes-Tóth G
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):311-6. PubMed ID: 9699885
[TBL] [Abstract][Full Text] [Related]
8. 11 beta-Hydroxysteroid dehydrogenase type 2 complementary deoxyribonucleic acid stably transfected into Chinese hamster ovary cells: specific inhibition by 11 alpha-hydroxyprogesterone.
Morita H; Zhou M; Foecking MF; Gomez-Sanchez EP; Cozza EN; Gomez-Sanchez CE
Endocrinology; 1996 Jun; 137(6):2308-14. PubMed ID: 8641180
[TBL] [Abstract][Full Text] [Related]
9. Human 11beta-hydroxysteroid dehydrogenase type 1 is enzymatically active in its nonglycosylated form.
Blum A; Martin HJ; Maser E
Biochem Biophys Res Commun; 2000 Sep; 276(2):428-34. PubMed ID: 11027492
[TBL] [Abstract][Full Text] [Related]
10. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines.
Bland R; Worker CA; Noble BS; Eyre LJ; Bujalska IJ; Sheppard MC; Stewart PM; Hewison M
J Endocrinol; 1999 Jun; 161(3):455-64. PubMed ID: 10333548
[TBL] [Abstract][Full Text] [Related]
12. 11beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension.
Hatakeyama H; Inaba S; Miyamori I
Hypertension; 1999 May; 33(5):1179-84. PubMed ID: 10334808
[TBL] [Abstract][Full Text] [Related]
13. 11Beta-hydroxysteroid dehydrogenase expression in first trimester human trophoblasts.
Arcuri F; Sestini S; Paulesu L; Bracci L; Carducci A; Manzoni F; Cardone C; Cintorino M
Mol Cell Endocrinol; 1998 Jun; 141(1-2):13-20. PubMed ID: 9723880
[TBL] [Abstract][Full Text] [Related]
14. Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state.
Li A; Li KX; Marui S; Krozowski ZS; Batista MC; Whorwood CB; Arnhold IJ; Shackleton CH; Mendonca BB; Stewart PM
J Hypertens; 1997 Dec; 15(12 Pt 1):1397-402. PubMed ID: 9431844
[TBL] [Abstract][Full Text] [Related]
15. LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors.
Leckie C; Chapman KE; Edwards CR; Seckl JR
Endocrinology; 1995 Dec; 136(12):5561-9. PubMed ID: 7588309
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of nuclear 11beta-hydroxysteroid dehydrogenase type 2 in mineralocorticoid receptor positive and negative tissues.
Petrelli MD; Lim-Tio SS; Condon J; Hewison M; Stewart PM
Endocrinology; 1997 Jul; 138(7):3077-80. PubMed ID: 9202257
[TBL] [Abstract][Full Text] [Related]
17. 11beta-hydroxysteroid dehydrogenase and corticosteroid action in lyon hypertensive rats.
Lloyd-MacGilp SA; Nelson SM; Florin M; Lo M; McKinnell J; Sassard J; Kenyon CJ
Hypertension; 1999 Nov; 34(5):1123-8. PubMed ID: 10567193
[TBL] [Abstract][Full Text] [Related]
18. Expression of 11beta-hydroxysteroid dehydrogenase type 2 in an ACTH-producing small cell lung cancer.
Parks LL; Turney MK; Gaitan D; Kovacs WJ
J Steroid Biochem Mol Biol; 1998 Nov; 67(4):341-6. PubMed ID: 9883991
[TBL] [Abstract][Full Text] [Related]
19. Cortisol-secreting adrenal adenomas express 11beta-hydroxysteroid dehydrogenase type-2 gene yet possess low 11beta-HSD2 activity.
Mazzocchi G; Aragona F; Malendowicz LK; Gottardo L; Nussdorfer GG
J Investig Med; 2001 Mar; 49(2):191-4. PubMed ID: 11288760
[TBL] [Abstract][Full Text] [Related]
20. 11beta-hydroxysteroid dehydrogenase expression and activity in the human adrenal cortex.
Mazzocchi G; Rossi GP; Neri G; Malendowicz LK; Albertin G; Nussdorfer GG
FASEB J; 1998 Nov; 12(14):1533-9. PubMed ID: 9806762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
